Literature DB >> 19848434

Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.

Sarah J Robinson1, Eric K Hoobler, Michelle Riener, Steven T Loveridge, Karen Tenney, Frederick A Valeriote, Theodore R Holman, Phillip Crews.   

Abstract

Enzyme screening of crude sponge extracts prioritized a 2005 Papua New Guinea collection of Hyrtios sp. for further study. The MeOH extract contained puupehenone and four puupehenone analogues (1, 2, 3, 5, and 7) along with a new diastereomer, 20-epi-hydroxyhaterumadienone (4), and a new analogue, 15-oxo-puupehenoic acid (6). The drimane terpene core of 4 and 6 was rapidly dereplicated, and the modified Mosher's method identified 4, while 1D and 2D NMR techniques were used to solve 6. These compounds plus noteworthy repository natural products and standards were tested against three lipoxygenase isozymes, human 5-, 12-, and 15-lipoxygenases. Significant potency and selectivity profiles were exhibited in the human 5-lipoxygenase assay by puupehenone (1) and jaspaquinol (9) and structural factors responsible for activity identified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848434      PMCID: PMC2996101          DOI: 10.1021/np900465e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  20 in total

1.  A new artificial cyclase for polyprenoids: enantioselective total synthesis of (-)-chromazonarol, (+)-8-epi-puupehedione, and (-)-11'-deoxytaondiol methyl ether.

Authors:  Hideaki Ishibashi; Kazuaki Ishihara; Hisashi Yamamoto
Journal:  J Am Chem Soc       Date:  2004-09-15       Impact factor: 15.419

2.  Probing the bioactive constituents from chemotypes of the sponge Psammocinia aff. bulbosa.

Authors:  Sarah J Robinson; Karen Tenney; Desiree F Yee; Lizabeth Martinez; Joseph E Media; Frederick A Valeriote; Rob W M van Soest; Phillip Crews
Journal:  J Nat Prod       Date:  2007-06-09       Impact factor: 4.050

Review 3.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

Authors:  R A Lewis; K F Austen; R J Soberman
Journal:  N Engl J Med       Date:  1990-09-06       Impact factor: 91.245

Review 4.  Histone deacetylases and cancer: causes and therapies.

Authors:  P Marks; R A Rifkind; V M Richon; R Breslow; T Miller; W K Kelly
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 5.  The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Authors:  R L Bell; P R Young; D Albert; C Lanni; J B Summers; D W Brooks; P Rubin; G W Carter
Journal:  Int J Immunopharmacol       Date:  1992-04

6.  Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.

Authors:  Taro Amagata; Stephanie Whitman; Tyler A Johnson; Chad C Stessman; Christopher P Loo; Emil Lobkovsky; Jon Clardy; Phillip Crews; Theodore R Holman
Journal:  J Nat Prod       Date:  2003-02       Impact factor: 4.050

7.  5-lipoxygenase inhibitory activity of zileuton.

Authors:  G W Carter; P R Young; D H Albert; J Bouska; R Dyer; R L Bell; J B Summers; D W Brooks
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

8.  Purification and characterization of recombinant histidine-tagged human platelet 12-lipoxygenase expressed in a baculovirus/insect cell system.

Authors:  X S Chen; A R Brash; C D Funk
Journal:  Eur J Biochem       Date:  1993-06-15

9.  Puupehenone congeners from an indo-pacific hyrtios sponge.

Authors:  Ivette C Piña; Miranda L Sanders; Phillip Crews
Journal:  J Nat Prod       Date:  2003-01       Impact factor: 4.050

10.  Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties.

Authors:  Tyler A Johnson; Karen Tenney; Robert H Cichewicz; Brandon I Morinaka; Kimberly N White; Taro Amagata; Balanehru Subramanian; Joseph Media; Susan L Mooberry; Frederick A Valeriote; Phillip Crews
Journal:  J Med Chem       Date:  2007-07-10       Impact factor: 7.446

View more
  22 in total

1.  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.

Authors:  Diane K Luci; J Brian Jameson; Adam Yasgar; Giovanni Diaz; Netra Joshi; Auric Kantz; Kate Markham; Steve Perry; Norine Kuhn; Jennifer Yeung; Edward H Kerns; Lena Schultz; Michael Holinstat; Jerry L Nadler; David A Taylor-Fishwick; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

3.  15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.

Authors:  Steven C Perry; Chakrapani Kalyanaraman; Benjamin E Tourdot; William S Conrad; Oluwayomi Akinkugbe; John Cody Freedman; Michael Holinstat; Matthew P Jacobson; Theodore R Holman
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

4.  Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.

Authors:  Michelle M Armstrong; Giovanni Diaz; Victor Kenyon; Theodore R Holman
Journal:  Bioorg Med Chem       Date:  2014-05-21       Impact factor: 3.641

5.  Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.

Authors:  Ganesha Rai; Victor Kenyon; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Eric Hoobler; William Leister; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

6.  A potent and selective inhibitor targeting human and murine 12/15-LOX.

Authors:  Michelle M Armstrong; Cody J Freedman; Joo Eun Jung; Yi Zheng; Chakrapani Kalyanaraman; Matthew P Jacobson; Anton Simeonov; David J Maloney; Klaus van Leyen; Ajit Jadhav; Theodore R Holman
Journal:  Bioorg Med Chem       Date:  2016-01-21       Impact factor: 3.641

7.  Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.

Authors:  Carolina Rodrigues Felix; Rashmi Gupta; Sandra Geden; Jill Roberts; Priscilla Winder; Shirley A Pomponi; Maria Cristina Diaz; John K Reed; Amy E Wright; Kyle H Rohde
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

8.  Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.

Authors:  Carolina Mascayano; Victoria Espinosa; Silvia Sepúlveda-Boza; Eric K Hoobler; Steve Perry; Giovanni Diaz; Theodore R Holman
Journal:  Chem Biol Drug Des       Date:  2014-11-28       Impact factor: 2.817

9.  Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1.

Authors:  Steven C Perry; Thomas Horn; Benjamin E Tourdot; Adriana Yamaguchi; Chakrapani Kalyanaraman; William S Conrad; Oluwayomi Akinkugbe; Michael Holinstat; Matthew P Jacobson; Theodore R Holman
Journal:  Biochemistry       Date:  2020-10-13       Impact factor: 3.162

10.  Structures and cytotoxic evaluation of new and known acyclic Ene-Ynes from an American Samoa Petrosia sp. Sponge.

Authors:  Eric J Mejia; Lindsay B Magranet; Nicole J De Voogd; Karen Tendyke; Dayong Qiu; Young Yongchun Shen; Zhongrui Zhou; Phillip Crews
Journal:  J Nat Prod       Date:  2013-01-31       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.